awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34909445-7622CB9C-2D35-4B80-B51A-BA4EDEB25F50
Q34909445-7622CB9C-2D35-4B80-B51A-BA4EDEB25F50
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34909445-7622CB9C-2D35-4B80-B51A-BA4EDEB25F50
Correct primary structure assessment and extensive glyco-profiling of cetuximab by a combination of intact, middle-up, middle-down and bottom-up ESI and MALDI mass spectrometry techniques.
P2860
Q34909445-7622CB9C-2D35-4B80-B51A-BA4EDEB25F50
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34909445-7622CB9C-2D35-4B80-B51A-BA4EDEB25F50
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cf2e44b98d9d3225dc9a94e8c691c3ec040a5122
P2860
Biosimilars: what clinicians should know.